BioShares Biotechnology Backtesting

BioShares Biotechnology Products -- USA Etf  

USD 41.19  0.42  1.01%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of BioShares Biotechnology Products and determine expected loss or profit from investing in BioShares Biotechnology over given investment horizon. Check also BioShares Biotechnology Hype Analysis, BioShares Biotechnology Correlation, Portfolio Optimization, BioShares Biotechnology Volatility as well as analyze BioShares Biotechnology Alpha and Beta and BioShares Biotechnology Performance
 Time Horizon     30 Days    Login   to change
SymbolX
Backtest

BioShares Biotechnology 'What if' Analysis

December 18, 2017
0.00
No Change 0.00  0.0%
In 31 days
January 17, 2018
0.00
If you would invest  0.00  in BioShares Biotechnology on December 18, 2017 and sell it all today you would earn a total of 0.00 from holding BioShares Biotechnology Products or generate 0.0% return on investment in BioShares Biotechnology over 30 days. BioShares Biotechnology is related to or competes with Health Care, iShares Nasdaq, Vanguard Health, SPDR SP, iShares US, and iShares Global. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of...

BioShares Biotechnology Upside/Downside Indicators

  

BioShares Biotechnology Market Premium Indicators

BioShares Biotechnology lagged returns against current returns

 Current and Lagged Values 
      Timeline 

BioShares Biotechnology regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

BioShares Biotechnology Backtested Returns

We consider BioShares Biotechnology not too risky. BioShares Biotechnology secures Sharpe Ratio (or Efficiency) of 0.1741 which signifies that BioShares Biotechnology had 0.1741% of return per unit of risk over the last 1 month. Our philosophy towards foreseeing volatility of a etf is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for BioShares Biotechnology Products which you can use to evaluate future volatility of the entity. Please confirm BioShares Biotechnology Downside Deviation of 1.47, Risk Adjusted Performance of 0.0479 and Mean Deviation of 0.8262 to double-check if risk estimate we provide are consistent with the epected return of 0.1762%. The organization shows Beta (market volatility) of -1.4422 which signifies that as returns on market increase, returns on owning BioShares Biotechnology are expected to decrease by larger amounts. On the other hand, during market turmoil, BioShares Biotechnology is expected to significantly outperform it.. Although it is extremely important to respect BioShares Biotechnology historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing BioShares Biotechnology technical indicators you can presently evaluate if the expected return of 0.1762% will be sustainable into the future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.28) 

Weak reverse predictability

BioShares Biotechnology Products has weak reverse predictability. Overlapping area represents the amount of predictability between BioShares Biotechnology time series from December 18, 2017 to January 2, 2018 and January 2, 2018 to January 17, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioShares Biotechnology price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current BioShares Biotechnology price fluctuation can be explain by its past prices. Given that BioShares Biotechnology Products has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of BioShares Biotechnology for similar time interval.
Correlation Coefficient -0.28
Spearman Rank Test 0.21
Price Variance 0.13
Lagged Price Variance 0.23

BioShares Biotechnology Lagged Returns

 Regressed Prices 
      Timeline 

BioShares Biotechnology Performance vs DOW

The median price of BioShares Biotechnology for the period between Mon, Dec 18, 2017 and Wed, Jan 17, 2018 is 40.83 with a coefficient of variation of 1.56. The daily time series for the period is distributed with a sample standard deviation of 0.63, arithmetic mean of 40.63, and mean deviation of 0.53. The Etf did not receive any noticable media coverage during the period.
Price Growth (%)  
      Timeline